20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T4853 | TRIA-662 | 3-Carbamoyl-1-methylpyridinium Chloride,1-Methylnicotinamide chloride,1-methylpyridin-1-ium-3-carboxamide hydrochloride,Nicotinamide Chloromethylate | Others , Endogenous Metabolite |
TRIA-662 (Nicotinamide Chloromethylate) is a niacin metabolite excreted via the urinary system. | |||
T2S0504 | Ilexoside D | Others | |
Ilexoside D has ant-allergic, and anti-coagulant activities, it shows anti-tissue factor activity as well as the antithrombotic activity. | |||
T25741 | Linotroban | HN 11500,CL-871502 | PPAR |
Linotroban(CL-871502) is a potent selective thromboxane (TXA2) receptor antagonist with antithrombotic activity. | |||
T13210 | Trombodipine | PCA-4230 | Antibiotic |
Trombodipine (PCA-4230) is a platelet aggregation inhibitor with antithrombotic activity and protection against Listeria monocytogenes. | |||
T67991 | Iliparcil | Others | |
Iliparcil is an antithrombotic compound with oral activity. | |||
T4076 | Fondaparinux sodium | Natural heparin pentasaccharide Sodium,Fondaparin sodium,SR-90107A,Arixtra | Factor Xa |
Fondaparinux sodium (SR-90107A) is an antithrombin-dependent factor Xa inhibitor with antithrombotic activity. | |||
T27920 | LY 517717 | LY-517717,LY517717 | Factor Xa |
LY 517717 is an orally active inhibitor of coagulation factor Xa with antithrombotic activity for the study of venous thromboembolism (VTE). | |||
T27318 | Fidexaban | CI-1031,BX-807834,PD-200022,CI1031,BX807834,ZK-807834 | Factor Xa |
Fidexaban (CI1031) is a novel, potent, selective and orally active factor Xa inhibitor that has demonstrated antithrombotic activity in a variety of assays | |||
T80792 | WAY-639228 | Others | |
WAY-639228-A has potential antithrombotic and anticoagulant activity for the study of cerebral thrombosis. | |||
T13302 | Viquidil hydrochloride | Quinotoxine hydrochloride | Others |
Viquidil hydrochloride (Quinotoxine hydrochloride) is an isomer of Quinidine. Viquidil hydrochloride is an agent of cerebral vasodilator with antithrombotic activity. | |||
T17025 | Tecarfarin | ATI-5000,ATI-5923 | Others |
Tecarfarin (ATI-5923) is an orally active and potent vitamin K epoxide reductase (VKOR) antagonist and cannabinoid-1 receptor inverse agonist with antithrombotic activity that attenuates abdominal pain and increases inte... | |||
T63966 | BMS-986141 | UDM-003183 | Protease-activated Receptor |
BMS-986141(UDM-003183) is a selective and potent protease-activated receptor-4 (PAR-4) antagonist with oral activity and an IC50 value of 0.4 nM.BMS-98614 exhibits significant antithrombotic effects. | |||
TN1996 | Nothofagin | ERK , IL Receptor , TNF | |
Nothofagin has antioxidant, and antithrombotic activities, it possesses anti-inflammatory activity by inhibiting hyperpermeability, expression of CAMs, and adhesion and migration of leukocytes, thereby endorsing its usef... | |||
T17091 | Thrombin Inhibitor 2 | Others | |
Thrombin Inhibitor 2 is a small molecule direct thrombin inhibitor. Thrombin Inhibitor 2 has antithrombotic activity. | |||
T17024 | Tecarfarin sodium | ATI-5923 sodium | Others |
Tecarfarin sodium is a novel orally active non-competitive vitamin K epoxide reductase antagonist. Tecarfarin sodium has the antithrombotic activity. | |||
T70909 | AY 31390 | ||
AY 31390 is a phosphodiesterase (PDE) inhibitor with antithrombotic activity. | |||
T12782 | RWJ-445167 | 3DP-10017 | Factor Xa , Thrombin |
RWJ-445167 is a thrombin and factor Xa dual inhibitor(Ki of 4.0 nM and 230 nM, respectively), with potent antithrombotic activity. | |||
T70458 | FXIa-6f | ||
FXIa-6f is a high affinity, orally bioavailable macrocyclic FXIa inhibitor with antithrombotic activity in preclinical species | |||
T12694 | Razaxaban hydrochloride | BMS 561389 hydrochloride,DPC 906 hydrochloride | Others |
Razaxaban hydrochloride is a highly potent, selective and orally active inhibitor of factor Xa(Ki of 0.19 nM),has strongly antithrombotic activity. | |||
T36759 | SAR 216471 hydrochloride | ||
Potent P2Y12 antagonist (IC50 = 17 nM). Displays antiplatelet and antithrombotic activity in vivo. Orally available. Boldron et al (2014) N-[6-(4-butanoyl-5-methyl-1H-pyrazol-1-yl)pyridazin-3-yl]-5-chloro-1-[2-(4-methylp... |